E1	Condition:T1 Name:T2
E4	Procedure:T4 Name:T5
E6	Procedure:T6 Name:T7 Temporality:E27
E9	Age:T14 Eq-Comparison:E10
E10	Eq-Comparison:T20 Operator:T11 Value:T15
E11	Eq-Comparison:T21 Operator:T12 Temporal-Unit:T13 Value:T18
E2	And:T22 Arg:T3 Arg2:E9
E5	Assertion:T24 Asserted:E4
E7	Drug:T17 Name:T8
E8	Procedure:T9 Name:T25
E12	Procedure:T26 Name:T27
E13	Or:T28 Arg:E8 Arg2:E12
E14	Condition:T29 Name:T30
E15	Drug:T31
E16	Drug:T32 Temporality:E17
E17	Eq-Comparison:T33 Temporal-Period:T34
E18	Eq-Comparison:T35 Temporal-Period:T36
E19	Or:T37 Arg:E18 Arg2:E17
E20	Procedure:T38 Temporality:E11
E21	Temporal-Connection:T39 Arg:E11 Arg2:E16
E22	Drug:T40
E23	Temporal-Connection:T42 Arg:E22 Arg2:E26
E24	Observation:T19 Name:T43
E25	Negation:T44 Negates:E24
E26	Study:T41
E27	Eq-Comparison:T45 Temporal-Period:T46
E28	Eq-Comparison:T47 Temporal-Period:T48
E3	Procedure:T16 Temporality:E28
E29	Study:T23 Study-Of:E15
E30	Study:T49 Study-Of:E16
E31	Study:T50 Study-Of:E22
E32	Observation:T51 Name:T52
E33	Assertion:T53 Asserted:E25
T1	Condition 66 64	Hunter syndrome
T2	Condition-Name 66 64	Hunter syndrome
T3	Life-Stage-And-Gender 76 74	Male
T4	Procedure 320 309	contraception
T5	Procedure-Name 320 309	contraception
T6	Procedure 427 409	bronchotomy
T7	Procedure-Name 427 409	bronchotomy
T10	Life-Stage-And-Gender 804 774	Female
T11	Eq-Operator 92 90	≥
T12	Eq-Operator 660 638	within
T13	Eq-Temporal-Unit 669 646	days
T14	Age 87 85	age
T15	Eq-Value 95 92	5
T18	Eq-Value 664 641	30
T20	Eq-Comparison 95 92	≥ 5
T21	Eq-Comparison 669 646	within 30 days
T22	And 79 77	at
T24	Assertion 306 295	Consent to
T17	Drug 399 381	iduronate-2-sulfatase ERT
T8	Drug-Name 399 381	iduronate-2-sulfatase ERT
T9	Procedure 455 436	bone marrow trasplanation
T25	Procedure-Name 455 436	bone marrow trasplanation
T26	Procedure 486 466	cord blood transplanation
T27	Procedure-Name 486 466	cord blood transplanation
T28	Or 460 440	or
T29	Condition 517 495	hypersensitivity
T30	Condition-Name 517 495	hypersensitivity
T31	Drug 582 560	product
T32	Drug 653 631	products
T33	Eq-Comparison 604 582	planned
T34	Eq-Temporal-Period 604 582	planned
T35	Eq-Comparison 593 571	Prior
T36	Eq-Temporal-Period 593 571	Prior
T37	Or 596 574	or
T38	Procedure 686 663	treatment
T39	Temporal-Connection 676 653	before
T40	Drug 719 696	product
T42	Temporal-Connection 743 720	duirng
T19	Observation 789 761	6-MWT
T43	Observation-Name 789 761	6-MWT
T44	Negation 769 744	Unable
T41	Study 754 731	study
T45	Eq-Comparison 412 394	History
T46	Eq-Temporal-Period 412 394	History
T47	Eq-Comparison 353 340	Prior
T48	Eq-Temporal-Period 353 340	Prior
T16	Procedure 363 350	treatment
T23	Study 574 552	invetigational
T49	Study 644 622	investigational
T50	Study 711 688	investigational
T51	Observation 141 133	6-MWT
T52	Observation-Name 141 133	6-MWT
T53	Assertion 769 744	Unable
A1	Life-Stage-And-Gender-Type T3 male
A2	Life-Stage-And-Gender-Type T10 male
A3	Eq-Operator-Value T11 GTEQ
A4	Eq-Operator-Value T12 LTEQ
A5	Eq-Temporal-Unit-Value T13 day
A6	Assertion-Type-Value E5 hypothetical
A7	Eq-Temporal-Period-Value T34 future
A8	Eq-Temporal-Period-Value T36 past
A9	Temporal-Connection-Type-Value E21 before
A10	Temporal-Connection-Type-Value E23 during
A11	Eq-Temporal-Period-Value T46 past
A12	Eq-Temporal-Period-Value T48 past
A13	Assertion-Type-Value E33 hypothetical
R2	Using Arg1:E20 Arg2:E22
R3	Using Arg1:E3 Arg2:E7
R1	Caused-By Arg1:E14 Arg2:E15